[ Price : $8.95]
FDA announces the award of two new animal drug research grants for minor use/minor species studies in Iowa and Montana.[ Price : $8.95]
FDA grants Catalyst Pharmaceutical Partners an orphan drug designation for CPP-115, a novel GABA aminotransferase inhibitor for tr...[ Price : $8.95]
Six cardiovascular societies worldwide issue guidelines on live case demonstrations with a companion FDA document.[ Price : $8.95]
Apricus Biosciences says it will submit for FDA review a Phase 3 SPA trial for its RavVa to treat Raynauds syndrome secondary to s...[ Price : $8.95]
FDA updates a Hospira Class I recall involving its Symbiq One and two Channel Infuser infusion pumps to reinforce mitigation steps...[ Price : $8.95]
FDA clears a Phadia 510(k) for the EliA GliadinDP IgA and EliA GliadinDP IgG (deamidated peptides) assays for use in diagnosing Ce...[ Price : $8.95]
A New England Journal of Medicine editorial faults GlaxoSmithKline for refusing to provide drugs and placebos for government-spons...[ Price : $8.95]
FDA says five companies are recalling products containing aromatase inhibitors they marketed as dietary supplements.